142 related articles for article (PubMed ID: 33347833)
1. Risk factors for lymph node metastasis and survival of patients with nonampullary duodenal carcinoid tumors treated with endoscopic therapy versus surgical resection: analysis of the Surveillance, Epidemiology, and End Results program.
Wang R; Mohapatra S; Jovani M; Akshintala VS; Kamal A; Brewer OG; Kumbhari V; Shin EJ; Canto MI; Khashab MA; Singh VK; Lennon AM; Kalloo AN; Ngamruengphong S
Gastrointest Endosc; 2021 Jun; 93(6):1384-1392. PubMed ID: 33347833
[TBL] [Abstract][Full Text] [Related]
2. Metastasis Prevalence and Survival of Patients with T1-2 Gastric Neuroendocrine Tumor Treated with Endoscopic Therapy and Surgery.
Wang M; Cheng S; Zhu L; Xu T; Zhang J; Zhang Y; Ping J; Wang R
Dig Dis Sci; 2022 Jul; 67(7):3228-3238. PubMed ID: 34272627
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors.
Ngamruengphong S; Kamal A; Akshintala V; Hajiyeva G; Hanada Y; Chen YI; Sanaei O; Fluxa D; Haito Chavez Y; Kumbhari V; Singh VK; Lennon AM; Canto MI; Khashab MA
Gastrointest Endosc; 2019 Mar; 89(3):602-606. PubMed ID: 30447216
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of endoscopic resection for well-differentiated nonampullary duodenal neuroendocrine tumors.
Wang Y; Ren Z; Shen YH; Fang XG; Li QL; Zhong YS; Zhang YQ; Chen WF; Zhou PH; Lin SL
Gastrointest Endosc; 2024 Feb; ():. PubMed ID: 38431107
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for metastasis and survival of patients with T1 gastric neuroendocrine carcinoma treated with endoscopic therapy versus surgical resection.
Ye H; Yuan Y; Chen P; Zheng Q
Surg Endosc; 2022 Aug; 36(8):6162-6169. PubMed ID: 35507062
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for lymph node metastasis in duodenal neuroendocrine tumors: A retrospective, single-center study.
Park SG; Lee BE; Kim GH; Park JW; Lee MW; Kim SJ; Choi CW; Lee S; Park DY
Medicine (Baltimore); 2019 Jun; 98(23):e15885. PubMed ID: 31169696
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
8. Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor.
Matsueda K; Kanesaka T; Kitamura M; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Honma K; Miyashiro I; Ishihara R
J Gastroenterol Hepatol; 2021 Dec; 36(12):3329-3336. PubMed ID: 34142385
[TBL] [Abstract][Full Text] [Related]
9. Risk of metastasis and survival in patients undergoing different treatment strategies with T1 colonic neuroendocrine tumors.
Wu X; Peng C; Lin M; Li Z; Yang X; Liu J; Yang X; Zuo X
J Endocrinol Invest; 2024 Mar; 47(3):671-681. PubMed ID: 37653287
[TBL] [Abstract][Full Text] [Related]
10. A modified duodenal neuroendocrine tumor staging schema better defines the risk of lymph node metastasis and disease-free survival.
Kachare SD; Liner KR; Vohra NA; Zervos EE; Fitzgerald TL
Am Surg; 2014 Aug; 80(8):821-6. PubMed ID: 25105406
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.
Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L
Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980
[No Abstract] [Full Text] [Related]
12. Comparable long-term survival outcomes of endoscopic therapy versus surgical therapy for T1-2N0M0 duodenal neuroendocrine tumors.
Liu Z; Gao J; Wang P; Yin F; Zeng C; Chen Y
Surg Endosc; 2023 Jul; 37(7):5444-5452. PubMed ID: 37036503
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
[No Abstract] [Full Text] [Related]
14. The Risk Factors for Metastasis in Non-Ampullary Duodenal Neuroendocrine Tumors Measuring 20 mm or Less in Diameter.
Hatta W; Koike T; Iijima K; Asanuma K; Asano N; Musha H; Inomata Y; Sano T; Endo H; Ikehata A; Horii T; Ohyauchi M; Yokosawa S; Kasajima A; Fujishima F; Sasano H; Nakaya N; Nakamura T; Shimosegawa T
Digestion; 2017; 95(3):201-209. PubMed ID: 28315861
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic and surgical treatment of T1N0M0 colorectal neuroendocrine tumors: a population-based comparative study.
Zhu H; Zhao S; Zhang C; Ji K; Wu W; Yin L; Yan H; Zhou J; Tang R; Miao L
Surg Endosc; 2022 Apr; 36(4):2488-2498. PubMed ID: 33987767
[TBL] [Abstract][Full Text] [Related]
16. Effects of endoscopic therapy and surgical resection on long-term survival outcomes in patients with duodenal gastrointestinal stromal tumors: a surveillance, epidemiology, and end result program analysis.
Yan H; Liu X; Yin L; Han H; Jin Y; Zhu X; Liu Z
Surg Endosc; 2022 Nov; 36(11):8030-8038. PubMed ID: 35437643
[TBL] [Abstract][Full Text] [Related]
17. Treatment Results of Endoscopic Mucosal Resection with a Ligation Device for Duodenal Neuroendocrine Tumors.
Fujimoto A; Sasaki M; Goto O; Maehata T; Ochiai Y; Kato M; Nakayama A; Akimoto T; Kuramoto J; Hayashi Y; Kameyama K; Yahagi N
Intern Med; 2019 Mar; 58(6):773-777. PubMed ID: 30449790
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.
Dubecz A; Kern M; Solymosi N; Schweigert M; Stein HJ
Ann Thorac Surg; 2015 Jun; 99(6):1879-85; discussion 1886. PubMed ID: 25929888
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
[TBL] [Abstract][Full Text] [Related]
20. Tumor size and depth predict rate of lymph node metastasis and utilization of lymph node sampling in surgically managed gastric carcinoids.
Saund MS; Al Natour RH; Sharma AM; Huang Q; Boosalis VA; Gold JS
Ann Surg Oncol; 2011 Oct; 18(10):2826-32. PubMed ID: 21455598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
